Correlation Between Verastem and COSCIENS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verastem and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and COSCIENS Biopharma, you can compare the effects of market volatilities on Verastem and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and COSCIENS Biopharma.

Diversification Opportunities for Verastem and COSCIENS Biopharma

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Verastem and COSCIENS is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Verastem i.e., Verastem and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Verastem and COSCIENS Biopharma

Given the investment horizon of 90 days Verastem is expected to generate 1.55 times more return on investment than COSCIENS Biopharma. However, Verastem is 1.55 times more volatile than COSCIENS Biopharma. It trades about 0.28 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest  390.00  in Verastem on September 4, 2024 and sell it today you would earn a total of  162.00  from holding Verastem or generate 41.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Verastem  vs.  COSCIENS Biopharma

 Performance 
       Timeline  
Verastem 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.
COSCIENS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Verastem and COSCIENS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verastem and COSCIENS Biopharma

The main advantage of trading using opposite Verastem and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.
The idea behind Verastem and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities